Anchorage Capital Group, L.L.C.

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), Anchorage Capital Group, L.L.C. reported 3 stock positions worth $117.4 million. Its top holding was Sentinelone Class A (S) at 74.1% of the portfolio, followed by Ginkgo Bioworks (DNA, 21.7%) and Ardagh Metal Packaging (AMBP, 4.2%). Compared with Q2 2025, it sold out of 2. The biggest sale was an exit from Frontier Communications Pare (FYBR).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001300714
Portfolio Value
$117.4M (Q3 2025)
SEC Filing
0000905148-25-004039 ↗ filed Nov 14, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $377.5M Q1 2024 Q2 2024: $316.7M Q2 2024 Q3 2024: $374.8M Q3 2024 Q4 2024: $272.5M Q4 2024 Q1 2025: $239.9M Q1 2025 Q2 2025: $258.7M Q2 2025 Q3 2025: $117.4M $117.4M Q3 2025 Q4 2025: $88.6M Q4 2025 Q1 2026: $436.3M Q1 2026 Q2 2026: $450.5M Q2 2026

Holdings 3 stocks · $117.4M
S Sentinelone Inc. Class A 74.06% 4,937,053 $86.9M No change
DNA Ginkgo Bioworks Holdings Inc. 21.69% 1,746,363 $25.5M No change
AMBP Ardagh Metal Packaging SA 4.25% 1,250,000 $5.0M No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $16K (not counted above)
SecurityClassShares / PrincipalValueChange
AMPWF Ardagh Metal Packaging -CW26 *W EXP 08/04/202 1,245,385$16KNo change

Total filed on the 13F, all lines: $117.4M.

Portfolio Sells Q2 2025 → Q3 2025
FYBR Frontier Communications Pare Sold out 0.00% −34.39
ROIV Roivant Sciences Ltd. Sold out 0.00% −21.06

Portfolio Buys Q2 2025 → Q3 2025
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$450.5MEQPT, S, DNA
Q1 2026 3$436.3MEQPT, S, DNA
Q4 2025 2$88.6MS, DNA
Q3 2025 3$117.4MS, DNA, AMBP
Q2 2025 5$258.7MS, FYBR, ROIV, DNA, AMBP
Q1 2025 5$239.9MS, FYBR, ROIV, DNA, AMBP
Q4 2024 5$272.5MS, FYBR, ROIV, DNA, AMBP
Q3 2024 5$374.8MFYBR, S, ROIV, DNA, AMBP
Q2 2024 5$316.7MFYBR, S, ROIV, DNA, AMBP
Q1 2024 6$377.5MFYBR, S, DNA, ROIV, AMBP